Yixuan Gong

Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors

Marissa N. Balak, Yixuan Gong, Gregory J. Riely et al. · Clinical Cancer Research · 2006 · 829 citations

Medicine, Oncology, Pharmacology +14

Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer

Lucía Regales, Yixuan Gong, Ronglai Shen et al. · Journal of Clinical Investigation · 2009 · 366 citations · Full text

Medicine, Oncology, Pharmacology +17

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

Li Wang, Abdel Saci, Péter M. Szabó et al. · Nature Communications · 2018 · 331 citations · Full text

Medicine, Cancer Biology, Oncology +17

Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas

Yixuan Gong, Romel Somwar, Katerina Politi et al. · PLoS Medicine · 2007 · 315 citations · Full text

Medicine, Oncology, Pharmacology +17

Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression

Yixuan Gong, Uma Chippada-Venkata, William Oh · Cancers · 2014 · 223 citations · Full text

Medicine, Molecular Biology, Oncology +11